Pavilion Capital Partners

Lhoopa is a property technology venture focused on transforming the affordable housing landscape in emerging markets. By utilizing data and innovative approaches, the company partners with local stakeholders to facilitate the provision of affordable homes, effectively addressing the substantial housing deficit in these regions. Additionally, Lhoopa operates as a real estate investment firm, helping clients navigate the buying and selling of properties, which includes various types of real estate transactions such as raw lots, development projects, and rental markets. This dual approach enables Lhoopa to customize solutions for its partners, fostering high returns for investors and promoting sustainable growth within the real estate sector.

Rebellions.ai is a developer of artificial intelligence semiconductor-based solutions focused on creating AI accelerators that connect core semiconductor architectures with deep learning algorithms. The company aims to deliver domain-specific AI processors alongside optimized software, effectively bridging the gap between silicon technology and advanced AI applications. By re-architecting AI processors to integrate specialized deep learning kernels, Rebellions enables clients to utilize energy-efficient AI hardware that seamlessly integrates into their operations. This approach allows clients to maximize the potential of their silicon resources while enhancing performance in AI-driven tasks.

Fleet Space Technologies is an Australian space technology company that operates a fleet of commercial micro-satellites aimed at transforming critical mineral discovery and space exploration. The company has developed innovative solutions, including the world's first 3D-printed all-metal patch antenna for space, which significantly enhances data throughput. Fleet utilizes its satellite constellation to facilitate the exploration of critical minerals globally and provides satellite-enabled systems and seismic array technology to connect Earth, the Moon, and Mars. By offering low-cost satellite-based systems for Industrial Internet of Things applications, Fleet Space Technologies seeks to revolutionize the mineral exploration and defense sectors while advancing space exploration initiatives.

EcoSpirits is a company focused on creating a closed-loop distribution system aimed at minimizing packaging waste within the premium spirits supply chain. It has developed innovative technology that includes a fully reusable, tamper-proof, and shock-proof glass vessel, alongside a semi-automated facility for sanitizing, refilling, and sealing spirits. This approach not only significantly reduces packaging and transport costs for businesses but also leads to a substantial reduction in carbon footprints. By streamlining the distribution process, EcoSpirits offers a sustainable alternative that benefits both the environment and the bottom line.

Travelio is an online marketplace for short-term home rentals, offering a diverse range of accommodations, including apartments, villas, and houses. Founded on March 24, 2015, by Christine Amanda, Christina Suriadjaja, and Hendry Rusli, the platform simplifies the property rental process for both renters and property owners. It enables clients to easily reserve and select their desired accommodations online while providing property owners and developers with tools to lease and manage their vacant properties effectively. Travelio aims to enhance the rental experience by connecting travelers with suitable housing options.

Flare Therapeutics is a biotechnology company focused on developing small molecule medicines by exploring the biology of transcription factors. The company aims to identify 'switch sites,' which are druggable regions crucial for regulating transcription factors, to target mutations associated with various diseases. Flare's innovative approach has advanced its drug discovery efforts, resulting in a promising pipeline of programs that primarily address well-established transcription factors. Initially concentrating on precision oncology, the company's research also holds potential applications in neurology, rare genetic disorders, immunology, and inflammation. By leveraging insights from its scientific founders, Flare Therapeutics seeks to transform the treatment landscape for cancer patients and other disease areas.

Medigo is a telehealth platform that specializes in providing on-demand medicine prescription and delivery services. The platform is equipped with a 24/7 quick medicine delivery service that guarantees customers receive their medication as quickly as possible within 20 minutes, even during emergencies. Additionally, Medigo offers home testing services that allow customers to perform various health tests in the comfort of their own homes, such as blood tests, urine tests, and pregnancy tests. Through its digital transformation initiatives, the platform strives to optimize its operations and enhance the mental and physical well-being of the community.

JNPMEDI is focused on advancing the Korean medical infrastructure by developing a medical data platform that supports clinical research and trial operations. The company specializes in providing digital solutions that enhance the capabilities of regulatory authorities, pharmaceutical companies, and clinical research organizations. By offering clinical cloud alternatives, JNPMEDI enables healthcare professionals to effectively execute, manage, monitor, and audit clinical trials, thereby facilitating the progress of medical research and improving overall healthcare outcomes.

Vow Foods is a company that specializes in producing cultivated exotic meat through lab-based methods. By utilizing animal cells rather than traditional livestock, Vow aims to create sustainable and ethical meat alternatives. The process involves harvesting animal cells via biopsy and growing them in a nutrient-rich medium, which allows for the development of a diverse range of meat products. This innovative approach not only provides consumers, restaurants, and chefs with nutritious and flavorful options but also reduces reliance on natural resources typically used in conventional meat production.

Starfire Energy, founded in 2007 and based in Aurora, Colorado, focuses on the development and deployment of sustainable energy technologies. The company has created a process for synthesizing clean liquid fuel, specifically ammonia, from renewable energy sources such as wind and solar power. This carbon-free ammonia serves multiple purposes, including use as fertilizer, refrigerant, and energy-dense fuel. Starfire Energy's modular systems, designed for easy on-site installation, utilize only renewable energy, air, and water as inputs, thereby supporting clients' needs for energy storage, transportation, heating, and industrial applications while promoting sustainability and reducing carbon emissions.

LevitasBio is focused on advancing cellular analytics through its innovative magnetic levitation technology. This platform, known as LeviCell, allows for the label-free purification of cells and nuclei, enabling researchers to analyze biological signatures without altering or damaging the samples. By overcoming traditional limitations in cellular analysis, LevitasBio's approach facilitates the study of high-value primary samples and sensitive cell types, regardless of their initial conditions. This capability provides significant advantages for scientists in the life sciences and healthcare sectors, allowing for a deeper and more accurate understanding of biological processes.

Asuene is a company focused on renewable power retail services that facilitate local production and consumption of energy. Additionally, it has developed a carbon management platform aimed at assisting organizations in tracking, managing, and reporting their greenhouse gas emissions and other environmental impacts. Utilizing artificial intelligence, the platform integrates various data sources to collect emissions information and formulate strategies for reducing pollutants over time. This enables organizations to effectively manage their environmental footprint, comply with regulatory requirements, and work towards their sustainability objectives.

Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

MOMA Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2019. The company focuses on discovering precision medicines by targeting molecular machines that are fundamental to human disease. MOMA Therapeutics utilizes a unique platform that leverages the common features of the ATPase target class, which includes significant conformational changes and energy-driven mechanics. By combining these insights with advancements in structural biology and small-molecule drug discovery, MOMA Therapeutics aims to develop drugs targeting previously challenging enzymes, contributing to the next generation of targeted therapies. The company was formerly known as ATPases NewCo, Inc. before rebranding in March 2020.

RVAC Medicines is an mRNA platform company founded in 2021 and based in Singapore. It focuses on developing a diverse pipeline of innovative vaccines and therapeutics to address unmet medical needs, particularly in emerging markets. The company is dedicated to producing cutting-edge mRNA and nucleic acid delivery technologies through its advanced GMP manufacturing facilities. RVAC Medicines offers end-to-end manufacturing capabilities and supports process scale-up and technology transfer, allowing for the development of both single and multi-mRNA/DNA products. This infrastructure aims to empower healthcare professionals in their efforts to combat infectious diseases.

Swatch On operates a fabric marketplace designed to facilitate reliable fabric sourcing for fashion designers. Launched with the goal of offering a diverse selection of unique, high-quality wholesale fabrics at competitive prices, Swatch On has developed a comprehensive database of fabrics sourced from Dongdaemun. The company prides itself on its team of young, creative, and motivated professionals who are passionate about fashion fabric. Their personalized approach ensures that clients receive tailored assistance in finding the perfect materials for their collections, enhancing the overall experience of sourcing fabrics for design projects.

ENSEM Therapeutics is an innovative drug discovery and development company focused on creating precision medicines for oncology. Utilizing its Kinetic Ensemble platform, the company aims to discover and develop transformative small-molecule therapies that address complex drug targets associated with cancer. By integrating advanced technologies, ENSEM Therapeutics can detect and characterize rare conformational states in drug targets, which are crucial for understanding oncogenic processes, regulatory mechanisms, and drug resistance. This approach opens new avenues for therapeutic intervention, allowing drug developers to target high-value and challenging areas within oncology while also considering potential applications in genetic disorders and other diseases.

Synspective Inc., based in Tokyo, Japan, specializes in satellite data technology that leverages synthetic aperture radar (SAR) satellite constellations, big data, and machine learning. The company provides remote sensing and satellite imagery services, utilizing small-sized SAR satellites capable of monitoring human activity across extensive areas, irrespective of time or weather conditions. Its offerings cater to various sectors, including urban design, infrastructure, energy, insurance, and finance, while also supporting government agencies in their data needs. By integrating advanced satellite data with analytical tools, Synspective aims to assist clients in achieving sustainable development and resilient urban growth.

ArkEdge Space is a manufacturer of microsatellites aimed at promoting space development and usage. The company develops and tests an ultra-small spacecraft that is responsible for communication and positioning systems for lunar activities, as well as establishes a method for cost reduction and mass production of high-performance 6U satellites, allowing businesses in positioning and communication technology to benefit the community by meeting their space needs.

Rokt is a software development company that specializes in e-commerce technology aimed at enhancing the consumer purchasing experience. By integrating marketing directly into the transaction moment, Rokt connects advertisers to customers, allowing for the placement of native advertisements within the transactional flows of e-commerce sites. This strategic positioning occurs at a time when consumers are most receptive to marketing messages, enabling e-commerce operators to increase revenue while providing a more effective customer experience. Rokt's solutions not only facilitate greater social engagement but also promote higher cross-selling opportunities for brands, thereby transforming the landscape of online shopping.

UrBox is a prominent electronic gift company in Vietnam, specializing in digitizing gift solutions through a platform that connects businesses with a vast network of over 3,000 suppliers. The company focuses on streamlining gift and loyalty programs for businesses, helping them manage marketing initiatives more efficiently while reducing costs and resource expenditure. UrBox enables consumers to redeem their gifts easily, both online and offline, thereby enhancing customer engagement and satisfaction. With its experience in e-vouchers, UrBox serves a diverse range of large clients across various sectors, solidifying its position as a leader in the electronic gift market in Vietnam.

Space BD is a company focused on facilitating the industrialization of space by offering a comprehensive range of services tailored to address the challenges faced by businesses developing new technologies. By adopting a business-driven approach, Space BD aims to streamline access to space for scientists and organizations, thereby promoting the commercialization of low Earth orbit. The company positions itself as a one-stop solution for various space-related needs, ultimately seeking to simplify and enhance the process of space exploration and utilization for its clients.

HotSpot Therapeutics is a biotechnology startup based in Boston, Massachusetts, established in 2017. The company specializes in the development of allosteric therapies that target regulatory sites on proteins. Its innovative therapeutic platform is designed to identify hotspots and locate pathway treatments for cancer, metabolic disorders, and rare diseases. By leveraging a comprehensive database of hotspot structures and utilizing data science, HotSpot Therapeutics employs a multidisciplinary approach to drug discovery. This approach aims to enhance the effectiveness of treatments and improve patient outcomes across a range of conditions.

Hepmil Media Group is a technology-driven media company based in Southeast Asia that focuses on enhancing the lives of millions through engaging and entertaining content. It operates a media service platform designed to connect internet influencers with corporate clients. By partnering with content creators who possess substantial followings on various content-sharing platforms, Hepmil facilitates marketing activities that leverage the influence of these internet celebrities. The company offers localization and strategic direction to brands, ensuring effective collaboration between influencers and corporate partners. Through its innovative approach, Hepmil aims to create meaningful connections that benefit both content creators and businesses.

Linc'well Inc. is a Tokyo-based company that develops a software system specifically designed for the healthcare industry. Founded in 2018, Linc'well offers a software as a service (SaaS) platform that includes web inquiry, call handling, payment processing, and electronic medical record management. Additionally, the company supports clinic operations through its brand CLINIC FORE and provides online services such as medical supplement subscriptions. By focusing on technological solutions, Linc'well aims to address inefficiencies in medical institutions and enhance both patient experiences and clinic management efficiency. The company's offerings cater primarily to healthcare institutions and clinics.

Infinium is an electrofuels provider that specializes in creating synthetic fuels from renewable energy and waste carbon dioxide. The company focuses on manufacturing ultra-low carbon electrofuels, which serve as drop-in replacements for traditional petroleum-derived products, allowing clients to significantly reduce harmful greenhouse gas emissions in the transportation sector. Infinium's solutions not only contribute to decarbonizing transportation but also provide lower carbon alternatives for various chemical processes, including plastics production. By utilizing existing transportation systems, Infinium enables immediate impacts on carbon reduction targets without the need for capital- and time-intensive upgrades.

Accredify, headquartered in Singapore, is a leading provider of verifiable document solutions, serving over 900 clients across more than nine markets. The company specializes in the creation and issuance of tamper-proof digital documents that can be easily verified through its cloud-based platform, which has facilitated nearly 7 million verifications to date. Users can verify documents quickly by dragging and dropping them into an online portal, yielding instantaneous results. Initially focused on the higher education sector, Accredify has helped top universities in Asia with digital graduation certificates and transcripts. In response to the COVID-19 pandemic, the company expanded into healthcare by developing HealthCerts, digitally verifiable COVID-19 test results recognized in more than 32 countries. Accredify also offers a suite of APIs for seamless integration, allowing organizations to generate verifiable digital credentials efficiently. With a commitment to customer service, security, and legal compliance, Accredify aims to be the trusted solution for document management and verification globally.

Allay Therapeutics is focused on developing innovative pain management solutions aimed at improving post-surgical recovery for patients. The company utilizes a proprietary technology platform that integrates validated non-opioid analgesics with biopolymers to create dissolvable therapeutic products. These products are designed to deliver targeted pain relief at the surgical site over extended periods, significantly longer than conventional pain treatments. Allay's lead investigational product, ATX101, is currently undergoing evaluation in a Phase 2 clinical trial for total knee arthroplasty surgeries. With a team of experienced entrepreneurs, scientists, and clinicians based in the San Francisco Bay Area and Singapore, Allay Therapeutics is dedicated to transforming the approach to pain management and addressing the limitations associated with opioid use.

Founded in 2013, Hydrogenious Technoloiges is a spin-off of the University of Erlangen-Nuremberg by its CEO Dr. Daniel Teichmann and the three co-founders Prof. Wolfgang Arlt, Prof. Peter Wasserscheid and Prof. Eberhardt Schlücker. The need for safe and efficient hydrogen storage for multi-MWh energy storage systems and safe and reliable hydrogen storage for hydrogen refuelling stations and fuel cell mobility was imminent – and Liquid Organic Hydrogen Carriers (LOHC) proved to be the solution. Having completed the technological proof of concept at the university’s laboratories, the idea became reality and Hydrogenious Technologies, a global pioneer in LOHC based energy storage, was born. With the University of Erlangen-Nuremberg becoming a shareholder in May 2014 and the successful close of a Series A funding round in July 2014 with Anglo American Platinum as investor, Hydrogenious Technologies is now backed with strong scientific, strategic and financial capacities to revolutionize large-scale energy and hydrogen storage.

Atama plus Inc. is an Edtech and SaaS company based in Tokyo, Japan, that specializes in providing education through artificial intelligence technology. Founded in 2017, the company offers AI-driven personalized learning programs tailored for elementary, middle, and high school students. By analyzing various data points, including learning history, proficiency levels, concentration abilities, and tendencies to forget, Atama plus develops adaptive learning experiences. This approach aims to help students acquire fundamental academic skills efficiently while also fostering their abilities to succeed in societal contexts.

Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

OY! is a fintech application based in Jakarta that aims to simplify financial management for its users. Founded in 2017 by Hilfi Alkaff, Jan Kristanto, and Jesayas Ferdinandus, the platform offers a free and user-friendly way to transfer money directly from debit cards, view bank account balances, and access bank statements. By integrating various financial products into a single platform, OY! enables clients to streamline their financial transactions, promoting financial wellness and saving time.

Standigm, Inc. is a South Korean company specializing in artificial intelligence technologies for the pharmaceutical industry, founded in 2015. It focuses on AI-driven drug discovery, employing its proprietary platforms to streamline the process from target identification to lead generation. Standigm's workflow automates molecular design through its DarkMolFactory™ and encompasses a full-stack approach to drug discovery with tools such as Standigm ASK™ for target identification, Standigm BEST™ for lead design, and Standigm Insight™ for drug repurposing. By leveraging advanced data analysis techniques, Standigm aims to enhance the efficiency of drug development, reducing both time and costs for pharmaceutical companies in bringing new drugs to market.

Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

KAHR Medical Ltd. is an immuno-oncology drug development company based in Jerusalem, Israel, founded in 2005. The company focuses on creating fusion protein pharmaceuticals aimed at treating cancer and autoimmune diseases. KAHR develops innovative drugs such as DSP105 and DSP106, which facilitate T-cell mediated tumor destruction, and DSP107, which targets CD47 tumors to activate phagocytes while delivering an immune costimulatory signal. Utilizing a unique platform of multifunctional immuno-recruitment proteins, KAHR's technology aims to enhance immune system recognition of cancer cells, thereby addressing the challenge of cancer evasion. This approach represents a significant advancement in protein-based pharmaceuticals, expanding treatment options for patients facing these serious health conditions.

Super Studio is a company that specializes in research and development, as well as the provision, operation, and maintenance of software and business solutions focused on enhancing e-commerce operations. It offers software-as-a-service (SaaS) solutions designed to improve efficiency in e-commerce processes, sales, and customer experience. Additionally, Super Studio provides direct-to-consumer consulting services that emphasize product planning and development, supply chain optimization, and after-sales customer relationship management. The company also features an enterprise collaboration platform that supports sales and marketing efforts, aiming to help businesses maximize their revenue and enhance overall customer engagement.

NiKang Therapeutics, Inc. is a biotechnology company established in 2017 and located in Wilmington, Delaware. The company is dedicated to discovering and developing innovative small molecule oncology medicines aimed at addressing unmet medical needs in cancer treatment. By employing a discovery approach that leverages target structure biology and structure-based drug design, NiKang Therapeutics aims to facilitate the rapid and efficient development of proprietary drug candidates with optimal pharmacological properties. The company seeks to enhance the treatment options available to healthcare providers, ultimately improving patient outcomes in the fight against cancer.

Inari is a biotechnology company focused on transforming agriculture to positively impact society and the environment. By emphasizing diversity in its operations, Inari fosters innovation aimed at developing a new food system. The company utilizes advanced technology, including predictive design and multiplex gene editing, to maximize the potential of seeds. Its distinctive SEEDesign platform enables the enhancement of various crops tailored to specific geographic conditions, facilitating the creation of innovative agricultural products with clear market strategies.

Blind is an anonymous professional network that enables verified individuals to connect and engage in meaningful discussions about workplace issues. With over 4.1 million users globally, the platform offers private channels for communication within companies as well as open forums for cross-industry interactions. This structure allows professionals to share valuable insights, such as job offer details and candid feedback about company culture, without the risk of judgment or retribution. By promoting transparency and open dialogue, Blind aims to flatten professional barriers, empowering users to make informed decisions and inspire positive changes in their work environments.

Studist operates a manual creation and sharing platform called "Teachme Biz," designed to enhance information transmission within enterprises. The platform enables users to create and share business manuals by selecting images and videos, supplemented with descriptive text. This approach aims to eliminate the loss of crucial information in organizations, facilitating efficient communication and knowledge sharing among employees. By providing a straightforward method for developing standard work procedure manuals, Studist contributes to a more informed workplace, supporting the vision of a society where intellectual vitality is fully visible and accessible.

Duckbill provides container trucking transportation services, international freight forwarding, and warehousing services by using big data and AI.

Sicepat Express provides several services to support businesses and puts forward practical solutions for e-commerce. SiCepat Ekspres has branches and outlets spread across cities in Indonesia. The company currently provides last-mile, warehousing and fulfillment, commerce-enabling services, online distribution, and middle-mile logistic. It was founded in 2004 and headquartered in Jakarta Pusat, Jakarta Raya.

ScaleFlux, Inc. is a semiconductor company based in San Jose, California, with additional offices in Beijing, Shanghai, and Hangzhou, China. Founded in 2014, ScaleFlux specializes in computational storage solutions that enhance the efficiency of data centers and cloud infrastructure. The company focuses on helping clients manage data growth effectively, particularly in areas such as cloud computing, artificial intelligence, and enterprise applications. By integrating advanced compute engines with solid-state storage, ScaleFlux enables users to improve performance, efficiency, security, and scalability for data-intensive tasks. In addition to its storage and memory products, ScaleFlux offers fully validated firmware, software, and module designs to facilitate product adoption, ensuring customers can leverage optimized storage intelligence to enhance their infrastructure for computing and storage needs.

Waresix is a logistics platform based in Jakarta, Indonesia, that specializes in freight forwarding, warehousing, and land transportation. The platform facilitates the connection between business owners and professional warehouse operators, allowing users to access on-demand warehouse services. Waresix addresses the growing demand for flexible warehousing solutions, particularly in the expanding e-commerce market. By matching unused warehouse space with businesses in need, the platform enables clients—including retailers, distributors, and manufacturers—to effectively manage inventory, adapt to variable demand, and streamline operations through features such as documentation management and billing.

Sociolla is an online beauty and personal care shopping platform based in Indonesia, designed to provide women with a convenient way to purchase a wide range of products, including makeup, skincare, haircare, and perfumes. The platform offers various items such as lip gloss, serums, lipsticks, eyeshadow palettes, hair oils, face masks, and more. Sociolla ensures the authenticity of its products by collaborating exclusively with authorized distributors and brand holders, emphasizing the importance of quality in beauty products that come into contact with the skin. The service also facilitates home delivery, enhancing the shopping experience for its customers.

Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California, that focuses on enhancing crop nutrition through the use of engineered microbes. The company leverages its deep understanding of the plant microbiome, employing engineering principles and data science to map microbial dynamics and develop beneficial traits. Pivot Bio's proprietary ON Technology utilizes naturally occurring microbes to provide crops with essential nutrients, particularly nitrogen, which is crucial for growth. This innovative approach aims to replace synthetic nitrogen fertilizers, thereby reducing the environmental impact associated with conventional farming practices. By enhancing crops' ability to capture and metabolize atmospheric nitrogen, Pivot Bio seeks to lower farming costs, improve crop yields, and contribute to a sustainable agricultural future that benefits both the planet and food supply.

Doctor Anywhere is a Singapore-based telehealth company that offers a comprehensive digital platform for on-demand healthcare solutions. It provides quick access to a range of health and wellness services, allowing users to consult licensed medical professionals for diagnoses, medications, and e-prescriptions from anywhere and at any time. The platform is designed to be simple and convenient, catering to the evolving lifestyle preferences of modern users. By leveraging technology, Doctor Anywhere aims to enhance health outcomes and address contemporary healthcare challenges, making it easier for individuals to manage their health according to their specific needs.

KAHR Medical Ltd. is an immuno-oncology drug development company based in Jerusalem, Israel, founded in 2005. The company focuses on creating fusion protein pharmaceuticals aimed at treating cancer and autoimmune diseases. KAHR develops innovative drugs such as DSP105 and DSP106, which facilitate T-cell mediated tumor destruction, and DSP107, which targets CD47 tumors to activate phagocytes while delivering an immune costimulatory signal. Utilizing a unique platform of multifunctional immuno-recruitment proteins, KAHR's technology aims to enhance immune system recognition of cancer cells, thereby addressing the challenge of cancer evasion. This approach represents a significant advancement in protein-based pharmaceuticals, expanding treatment options for patients facing these serious health conditions.

GudangAda is a business-to-business marketplace focused on transforming and digitalizing Indonesia's distribution chain for fast-moving consumer goods. The platform connects key stakeholders, including principals, distributors, wholesalers, and retailers, by providing an end-to-end digital solution that facilitates online transactions. It enables users to conduct both small and bulk transactions, allowing them to operate as both sellers and buyers. Additionally, GudangAda offers logistics services, merchant solutions, and financial services, enhancing efficiency and accessibility within the supply chain. By streamlining interactions among traders, the platform aims to improve turnover rates, reduce costs, and expand customer reach.

OY! is a fintech application based in Jakarta that aims to simplify financial management for its users. Founded in 2017 by Hilfi Alkaff, Jan Kristanto, and Jesayas Ferdinandus, the platform offers a free and user-friendly way to transfer money directly from debit cards, view bank account balances, and access bank statements. By integrating various financial products into a single platform, OY! enables clients to streamline their financial transactions, promoting financial wellness and saving time.

ReadCoor, Inc. is a technology company based in Cambridge, Massachusetts, specializing in the development and commercialization of a panomic spatial sequencing platform designed for researchers, clinicians, and pharmaceutical and diagnostics companies. The company's innovative platform, based on proprietary Fluorescent in situ Sequencing (FISSEQ) technology, enables the simultaneous detection and analysis of RNA, DNA, proteins, and therapeutics, while providing high-resolution three-dimensional imaging of tissue samples. This integration allows for comprehensive morphometric analysis and cellular localization, facilitating a deeper understanding of human biology and the advancement of therapeutic development. ReadCoor aims to support clients in accessing valuable clinical insights for treating various diseases, including cancer, infectious diseases, and neurological disorders. Established in 2016, ReadCoor operates as a subsidiary of 10x Genomics, Inc.

Appier Inc. is a technology company headquartered in Taipei, Taiwan, founded in 2012. It specializes in providing artificial intelligence platforms designed to enhance customer engagement and facilitate data-driven decision-making for enterprises. Appier offers a suite of products, including Aideal, which helps businesses influence purchase decisions and shorten sales cycles; AIQUA, a proactive platform for customer engagement based on user behavior; AIXON, a data science platform that consolidates customer data for predictive analytics; and CrossX, an AI-powered advertising solution for optimizing campaign performance. The company serves around 1,000 global brands and agencies and has a presence in 14 markets across Asia, including Singapore, Kuala Lumpur, Tokyo, and Sydney. Appier’s solutions allow businesses to leverage AI for improved targeting and customer retention, making it easier for them to operate in a cross-screen environment without needing extensive in-house AI expertise.

Travelio is an online marketplace for short-term home rentals, offering a diverse range of accommodations, including apartments, villas, and houses. Founded on March 24, 2015, by Christine Amanda, Christina Suriadjaja, and Hendry Rusli, the platform simplifies the property rental process for both renters and property owners. It enables clients to easily reserve and select their desired accommodations online while providing property owners and developers with tools to lease and manage their vacant properties effectively. Travelio aims to enhance the rental experience by connecting travelers with suitable housing options.

Neon Group is a global entertainment company headquartered in Singapore, specializing in creating and producing immersive experiences across various domains, including exhibitions, events, and interior architecture. The company has established partnerships with prominent organizations, including The Walt Disney Company, Marvel Entertainment, 20th Century Studios, and NBCUniversal, to develop popular themed exhibitions such as Marvel Avengers S.T.A.T.I.O.N. and Jurassic World: The Exhibition. Additionally, Neon collaborates with the governments of Peru and Egypt to present unique cultural experiences, showcasing original artifacts through exhibitions like Machu Picchu and Ramses the Great. With a commitment to delivering compelling and memorable experiences, Neon Group has successfully engaged millions of visitors across more than 60 cities worldwide, solidifying its position as a leader in the immersive entertainment industry.

Nuvation Bio Inc. is a biopharmaceutical company dedicated to addressing unmet needs in oncology through the development of novel therapies for challenging cancers. Founded in 2018 and headquartered in New York, with an additional office in San Francisco, Nuvation Bio focuses on treating patients whose conditions have not responded to conventional treatments. The company's leading clinical-stage candidate, NUV-868, is a BD2-selective oral small molecule BET inhibitor that targets the BRD4 protein, which plays a crucial role in regulating tumor growth and differentiation. In addition to NUV-868, Nuvation Bio is advancing a proprietary small molecule Drug-Drug Conjugate platform aimed at enhancing therapeutic efficacy. The company’s comprehensive portfolio includes multiple drug development candidates designed to meet the specific needs of cancer patients.

Structo is a digital manufacturing platform specializing in dental 3D printing services. The company has developed a range of application-specific 3D printing resins that complement its advanced hardware technology. By focusing on designing and implementing proprietary technology, Structo offers 3D printers that operate at higher speeds than traditional SLA printers. This innovative approach enables dental businesses to enhance their digital dentistry practices, achieving greater throughput and cost efficiency while maintaining high print quality.

ADVANCE.AI is a financial technology company focused on transforming the credit system through innovative data-driven solutions. With multiple offices across the Asia-Pacific region, it aims to create a more comprehensive and equitable alternative to traditional credit scoring methods. The company offers a big-data platform that includes anti-fraud detection services, assisting enterprises with loan applications through features such as multi-platform detection, face recognition, identity verification, company checks, and credit score analytics. By streamlining these processes, ADVANCE.AI helps businesses reduce manual verification costs and enhance operational efficiency. Founded by a team of experienced entrepreneurs and investors with backgrounds in prestigious institutions and industries, ADVANCE.AI is committed to building a better financial ecosystem.

Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

Edmicro is an education technology company that operates an online learning platform tailored for Vietnamese students. Established in 2018 and based in Hanoi, the company offers a cloud-computing solution named Onluyen, which facilitates self-learning through personalized experiences. The platform features a virtual classroom, a digital library, smart reporting, microlearning modules, and assessments to track progress and outcomes. Edmicro's technology automates the creation of educational resources, aligning content with specific learning objectives while adapting to individual learners' profiles and knowledge gaps. This comprehensive approach aims to enhance students' ability to learn, practice, and master their subjects effectively.

CyCraft is a cybersecurity solutions provider that specializes in protecting national governments, Fortune 500 companies, and small to medium enterprises. The company has developed an AI-driven platform, CyCraft AIR, which is recognized for its capabilities in endpoint detection and response, network detection and response, operational global threat intelligence, and enterprise cyber-health assessments. By focusing on autonomous systems and fostering collaboration between humans and artificial intelligence, CyCraft aims to enhance cyber resilience and deliver efficient return on investment for its clients.

Schrödinger is a healthcare-focused software company that specializes in computational drug design, serving pharmaceutical and biotechnology research sectors. Established in 1990, it offers a powerful computational platform that aids biopharmaceutical and industrial companies, as well as academic and government institutions, in their research efforts globally. Schrödinger operates through two main segments: Software and Drug Discovery. The Software segment supplies solutions aimed at enhancing the drug discovery process across the life sciences and materials science industries. Meanwhile, the Drug Discovery segment generates revenue through a portfolio of preclinical and clinical programs, both independently and through collaborative efforts. The company is committed to advancing science and talent to support its platform and has over 400 employees, engaging with customers and collaborators in more than 70 countries.

Fore Coffee is a specialty coffee shop based in Jakarta, Indonesia, founded in 2018. The company focuses on transforming coffee consumption through technology, offering a unique experience to its customers. Each cup of coffee is brewed using freshly roasted Arabica beans, which are meticulously sourced and developed into a rich espresso blend. This commitment to quality enables consumers to enjoy a strong and flavorful coffee, setting Fore Coffee apart in the competitive coffee market.

Warung Pintar Group is a micro retail technology company focused on digitalizing grassroots businesses in Indonesia. The company aims to empower underserved communities by enhancing the quality of street stalls through innovative solutions. Warung Pintar offers smart kiosk stores that feature modern amenities such as digital point-of-sale systems, free Wi-Fi, LCD screens, and power bank chargers. By leveraging data processing and analysis, the company provides valuable insights for financial inclusion and community engagement, fostering opportunities for social security and behavior analysis. Additionally, Warung Pintar assists aspiring entrepreneurs in securing land and funding to establish new shops, ultimately contributing to local economic development and impact monitoring within the community.

17LIVE Inc. is a live streaming platform that operates primarily in Taiwan, Japan, South Korea, Singapore, and Hong Kong. Founded in 2015 and headquartered in New Taipei City, Taiwan, the company offers its live streaming services under the 17 Media brand. Additionally, it provides online dating services through its Paktor and Goodnight brands. The platform enables users to share their life experiences and talents in real-time, fostering social connections and community engagement. 17LIVE aims to facilitate instant audio and video communication, allowing users to connect with others globally, regardless of their location. The company, which was formerly known as M17 Entertainment Limited, rebranded to 17LIVE Inc. in October 2020.

Airobotics offers a fully automated solution for collecting aerial data, catering to government, industrial, and commercial sectors. The company manufactures autonomous unmanned aerial drones that facilitate automated data capture and analysis. Airobotics' technology is utilized for a variety of applications, including real-time video monitoring, disaster assessments, compliance audits, land investigations, inspections, surveillance, progress tracking, and survey services. By providing these comprehensive capabilities, Airobotics enables organizations to gain valuable insights and improve operational efficiency.

Warung Pintar Group is a micro retail technology company focused on digitalizing grassroots businesses in Indonesia. The company aims to empower underserved communities by enhancing the quality of street stalls through innovative solutions. Warung Pintar offers smart kiosk stores that feature modern amenities such as digital point-of-sale systems, free Wi-Fi, LCD screens, and power bank chargers. By leveraging data processing and analysis, the company provides valuable insights for financial inclusion and community engagement, fostering opportunities for social security and behavior analysis. Additionally, Warung Pintar assists aspiring entrepreneurs in securing land and funding to establish new shops, ultimately contributing to local economic development and impact monitoring within the community.

Insilico Medicine, Inc. is a biotechnology company that utilizes artificial intelligence to advance drug discovery, biomarker development, and research into aging. Founded in 2014 and based in Baltimore, Maryland, the company has developed a comprehensive AI platform that employs techniques such as generative adversarial networks and reinforcement learning to create novel molecular structures aimed at treating cancer and age-related diseases. Insilico Medicine operates various projects, including Pharma.AI, which offers machine learning services to biotechnology and pharmaceutical companies, and Young.AI, which predicts biological age. The company is actively engaged in internal drug discovery efforts targeting conditions like Alzheimer's disease, Parkinson's disease, and diabetes, and has partnered with Life Extension to produce nutraceutical products using advanced bioinformatics. Additionally, Insilico Medicine provides consumer applications and services to academic institutions and the cosmetic industry, solidifying its role in the intersection of AI and healthcare.

Orchard Therapeutics is a biopharmaceutical company based in London, focused on developing innovative gene therapies for serious and life-threatening rare diseases. The company employs an autologous ex vivo gene therapy approach, which aims to modify a patient's hematopoietic stem cells to create a personalized treatment through a single administration. Orchard's product portfolio includes Strimvelis, the first gene therapy approved by the European Medicines Agency for adenosine deaminase-severe combined immunodeficiency (ADA-SCID). The company is advancing several clinical programs, including OTL-101 for ADA-SCID, OTL-200 for metachromatic leukodystrophy, OTL-103 for Wiskott-Aldrich syndrome, OTL-102 for X-linked chronic granulomatous disease, and OTL-300 for transfusion-dependent beta-thalassemia. Additionally, Orchard has a robust preclinical pipeline targeting various mucopolysaccharidosis types. Founded in 2015, Orchard Therapeutics collaborates with leading institutions in the field to enhance its research and development efforts.

Appier Inc. is a technology company headquartered in Taipei, Taiwan, founded in 2012. It specializes in providing artificial intelligence platforms designed to enhance customer engagement and facilitate data-driven decision-making for enterprises. Appier offers a suite of products, including Aideal, which helps businesses influence purchase decisions and shorten sales cycles; AIQUA, a proactive platform for customer engagement based on user behavior; AIXON, a data science platform that consolidates customer data for predictive analytics; and CrossX, an AI-powered advertising solution for optimizing campaign performance. The company serves around 1,000 global brands and agencies and has a presence in 14 markets across Asia, including Singapore, Kuala Lumpur, Tokyo, and Sydney. Appier’s solutions allow businesses to leverage AI for improved targeting and customer retention, making it easier for them to operate in a cross-screen environment without needing extensive in-house AI expertise.

SORACOM is a Tokyo-based company that specializes in providing an Internet of Things (IoT) platform designed to facilitate data communication for IoT and M2M (machine-to-machine) devices. The platform leverages scalable cloud technologies running on Amazon Web Services, enabling IoT solution developers to efficiently deploy and enhance their services while accommodating a variety of needs through flexible and customizable options. SORACOM enhances the security and reliability of data transfer across numerous devices and custom protocols, significantly reducing both time-to-market and costs associated with IoT services. Key offerings include SORACOM Air, which provides mobile data communication for IoT devices through its "Air SIM," allowing users to manage settings and monitor data traffic via a web console or API. Additionally, SORACOM Beam enables secure offloading of data from IoT devices to the cloud, ensuring high encryption and remote management capabilities without direct Internet exposure. Since its official launch in September 2015, SORACOM has positioned itself as a comprehensive provider of IoT solutions.

Ticket Monster Inc. is an e-commerce company in Korea today. In 2014, 70% of TMON’s transactions were completed on mobile devices and its customer base continued to expand into multiple age segments. The company operates in three key verticals - Goods, Local and Travel - and offers over 47,000 SKUs through partnerships with approximately 15,000 merchants.

STAR 360 is a Singapore-based retailer specializing in sports and fashion footwear. The company offers a diverse range of products, including casual, formal, and running footwear for both men and women, as well as sandals, sneakers, and specialized shoes for sports like tennis and volleyball. In addition to footwear, STAR 360 provides a variety of accessories such as bags and wallets, along with gym essentials like hydration products and masks. The company operates specialty stores and distributes its products globally, focusing on delivering high-quality items from various brands to meet the preferences of its customers.